Citadel Advisors »

Telomir Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Telomir Pharmaceuticals (TELO) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Telomir Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Telomir Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Telomir Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $17k 13k 1.28

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Micron Technology Call Option (MU)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Sandisk Corp (SNDK)
Advanced Micro Devices Call Option (AMD)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Amazon (AMZN)

View all positions for Citadel Advisors

Top funds holding Telomir Pharmaceuticals

Vanguard Capital Management
Geode Capital Management
BlackRock
Vanguard Fiduciary Trust
Northern Trust
State Street Corporation
Bank of New York Mellon
Captrust Financial Advisors
Advisor Group Holdings
Pensionmark Financial Group
Resources Investment Advisors
Qube Research & Technologies
Praetorian Wealth Management
Virtu Financial
Vestmark Advisory Solutions

View all funds holding Telomir Pharmaceuticals